临床儿科杂志 ›› 2020, Vol. 38 ›› Issue (2): 140-.doi: 10.3969/j.issn.1000-3606.2020.02.015

• 综合报道 • 上一篇    下一篇

不同评价工具在幼年皮肌炎病情评估中的应用价值

薛茹,卢燕鸣   

  1. 上海交通大学医学院附属仁济医院儿科(上海 200127)
  • 发布日期:2020-02-20
  • 通讯作者: 卢燕鸣 电子信箱:luyanming1973@aliyun.com

Clinical value of different assessment tools in disease assessment of juvenile dermatomyositis

XUE Ru, LU Yanming   

  1. Department of Pediatric, Ren Ji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
  • Published:2020-02-20

摘要:  目的 通过对不同评价工具用于儿童幼年皮肌炎病情活动度及严重程度评估的信效度检验及相关性分析, 确定不同评价工具的临床应用价值。方法 回顾分析2008年1月至2018年9月诊治的幼年皮肌炎患儿的临床资料,比较 入院当日及入院后24~48小时,利用儿童肌炎评定量表(CMAS)、肌炎活动性评价工具(MDAAT)、疾病活动性评分量表 (DAS)完成的病情评估的信度和效度。结果 共纳入35例患儿,包括2例多肌炎, 4例无肌病皮肌炎,29例典型皮肌炎; 男性15例,女性20例;平均起病年龄为(3.16±1.45)岁。血清酶学升高比例50.0%~95.5%。首发症状为皮疹、肌力减 退及二者共存者分别占60.0%、37.1%和2.9%。MDAAT、DAS、CMAS三种评价工具的Cronbach α系数均>0.8,组内相 关系数(ICC)均>0.75;KMO-Bartlett球形检验和探索性因子分析显示,以上评价工具结构效度均良好,各评价工具评分 在治疗前后的差异均有统计学意义(P均<0.05);其中DAS用时短,完成时间仅为(1.56±0.20)min。结论 MDAAT、 DAS、CMAS均具有较高的信度、效度,而DAS临床应用性更强。

关键词:  皮肌炎; 评价工具; 信度; 效度; 幼年

Abstract:  Objective To investigate clinical application values of different assessment tools in evaluating the activity and severity of juvenile dermatomyositis (JDM). Methods: Clinical data of children diagnosed with JDM in Ren Ji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine between January 2008 and September 2018 were collected, MDAAT (myositis disease activity assessment tool)/DAS (disease activity score)/CMAS (childhood myositis assessment scale) were performed to assess disease activity of JDM patients on the first day and after 24 - 48 h when they were in hospital. Results Of these 35 JDM children, 2 with JPM, 4 with CADM, 29 with JDM, 15 children were male, and 20 were female, the female to male ratio was 1.33:1, and the average age at disease onset was 3.16±1.45 years, the elevation of serum levels of muscle enzymes at the disease onset was 50%~95.5%, the proportion of first symptoms onset with rash, muscle weakness, and both were 60%, 37%, 3%, respectively. Cronbach α values were all >0.8 for MDAAT, DAS, and CMAS, internal correlation coefficient for MDAAT, DAS, and CMAS was 0.940, 0.957, 0.942 (>0.75), respectively;Construct validity was assessed by exploratory factor analysis according to the original questionnaires., which showed significant difference for scores between pre-therapy and post-therapy by MDAAT, DAS, and CMAS assessment (P<0.05). Conclusions The assessment tools, including MDAAT, DAS, CMAS, have a good reliability, validity and responsiveness. The DAS is the shortest to get answers, which has great value in clinical practice.

Key words:  juvenile; dermatomyositis; assessment tools; reliability; validity